Novo Nordisk CEO Mike Doustdar on $10B Metsera bid, expanding use of obesity drugs

31.4K views
•
November 5, 2025
by
CNBC Television
YouTube video player
Novo Nordisk CEO Mike Doustdar on $10B Metsera bid, expanding use of obesity drugs

Transcript

Novo Nordisk is out with results this morning now lowering its fullear profit uh and revenue uh forecast. Meanwhile, uh the company it's it's getting very interesting in terms uh of uh this possible uh bidding war uh that uh that we are seeing as we move that up a little bit please. That's what this means. Yeah, there you go. Keep going. Keep going... Read More

Explore YouTube Video Summarizer or Get YouTube Transcript Extractor

Read in Other Languages (beta)

English

Share This Summary 📚

Explore More Summaries from CNBC Television 📚

J.P. Morgan's Gabriella Santos: Fed cuts this cycle won’t inject extraordinary liquidity thumbnail
J.P. Morgan's Gabriella Santos: Fed cuts this cycle won’t inject extraordinary liquidity
CNBC Television
Trump administration weighs limits on proxy advisory firms & index fund managers: WSJ thumbnail
Trump administration weighs limits on proxy advisory firms & index fund managers: WSJ
CNBC Television
'Fast Money' traders talk Alphabet's record trading day thumbnail
'Fast Money' traders talk Alphabet's record trading day
CNBC Television
Citi CEO Jane Fraser: Some of the hype of in AI is earned, some of it is 'exuberant' thumbnail
Citi CEO Jane Fraser: Some of the hype of in AI is earned, some of it is 'exuberant'
CNBC Television
BlackRock files application with SEC for staked ether ETF: CNBC Crypto World thumbnail
BlackRock files application with SEC for staked ether ETF: CNBC Crypto World
CNBC Television
Tracking inflation without CPI: Here's what to know thumbnail
Tracking inflation without CPI: Here's what to know
CNBC Television